The winners of the 2021 International Clinical Researcher have been announced, find out who emerged victorious.
News
Novartis expands gene therapy pipeline with Arctos Medical takeover
Novartis will also add Arctos’ proprietary technology to its ophthalmology portfolio
FDA OKs Pfizer/BioNTech booster doses for higher-risk populations
Earlier this week, the NHS also began offering booster jab appointments for vulnerable groups
Valneva begins COVID-19 boosters in vaccine trial
Company will also begin recruiting adolescents into Phase III vaccine trial
AZ inks agreement with saRNA specialist VaxEquity
Under the partnership, AZ will support VaxEquity with research and development funding
CHMP recommends Nucala for three new indications
Positive opinions recommend approval for mAb in three additional eosinophil-driven diseases
Amgen to collab with Verastem on KRAS combination treatment
Agreement will evaluate Verastem’s dual RAF/MEK inhibitor with Amgen’s KRAS G12C inhibitor
New UK partnership aims to help build startup companies focused on cancer
Cancer Research UK has partnered with the University of Edinburgh’s ‘venture builder incubator’
Government review highlights the impact of overprescribing medicines
Review sets out practical and cultural changes to ensure patients get the most appropriate treatments
NHS patients gain access to COVID-19 treatment Ronapreve
Ronapreve will be targeted at hospitalised patients who have not mounted an antibody response against COVID-19
FDA approves Exelixis’ Cabometyx for differentiated thyroid cancer
Cabometyx found to reduce the risk of disease progression or death versus placebo in this patient population
Mirati’s adagrasib scores encouraging results in KRAS-mutated lung cancer
Adagrasib is an investigational oral small-molecule inhibitor of KRAS G12C
Positive topline results for Pfizer/BioNTech jab in five to 11-year-olds
Results showed vaccine has favourable safety profile in this age group
Enhertu reduces breast cancer disease progression or death by 72%
‘Groundbreaking results’ for the treatment of HER2-positive metastatic breast cancer
Promising early results for new ovarian cancer drug combo
Drug combination could offer a new option for treatment-resistant advanced ovarian cancer
